The laboratory-grown diamond market has accomplished in ten years what economists said would take a generation: it has fundamentally repriced the category below 3 carats, restructured the value chain from mine to retailer, and forced a strategic rethinking at De Beers that would have been unimaginable in 2010. Understanding what has happened, what the current price landscape looks like, and what it means for buyers of both natural and laboratory-grown material is no longer optional for anyone spending meaningfully in the diamond market.
The Price Collapse: What the Data Actually Shows
The wholesale price decline for laboratory-grown diamonds since 2016 is without precedent in any luxury goods category. In 2016, a 1-carat laboratory-grown diamond of D color and VS1 clarity retailed at approximately 80 percent of the price of its natural equivalent — roughly $4,500 versus $5,600 for comparable natural material. By 2020, that ratio had moved to approximately 50 percent. By mid-2024, laboratory-grown 1-carat rounds in comparable quality grades were retailing between $800 and $1,200 — approximately 15 to 20 percent of equivalent natural prices.
The collapse is supply-driven. Chemical Vapor Deposition (CVD) technology — the dominant production method for gem-quality laboratory diamonds — has scaled dramatically as reactor costs declined and production efficiency improved. A CVD reactor that cost $1 million and produced 20 carats per month in 2016 had a 2023 equivalent costing $250,000 and producing 400 carats per month. The Indian laboratory-grown diamond production cluster, centered on Surat, went from near-zero gem-quality output in 2018 to approximately 9 million carats annually by 2024 — roughly equal to the entire global natural rough supply from Botswana in a typical year.
The Zimbi Price Index, which tracks polished laboratory-grown diamond wholesale prices, showed an average year-over-year price decline of 37 percent in 2022, 41 percent in 2023, and 28 percent in the first half of 2024. These are not temporary corrections; they reflect structural cost reductions in a manufacturing process where the primary inputs are electricity, time, and reactor hardware — all of which are declining in cost as the industry matures.
The Natural Diamond Market Response: Segmentation and Narrative
The natural diamond market’s response to this disruption has been to accelerate a segmentation strategy that was implicit in the market’s structure but had never been explicitly articulated: investment-grade natural diamonds above 3 carats with documented quality characteristics are a different product from commodity diamonds used in fashion and engagement jewelry. The diamond miners, the major retailers, and the major auction houses have all moved toward this framing with varying degrees of coherence.
De Beers’ response has been the most publicly documented and the most strategically complex. In 2018, the company launched Lightbox, a laboratory-grown diamond brand positioned as fashion jewelry at transparently low prices ($800 per carat, sold direct to consumer). The strategy was intended to commoditize the laboratory-grown segment and prevent it from positioning as a value alternative to natural engagement rings. By pricing Lightbox aggressively and explicitly, De Beers attempted to draw a line between “fashion” laboratory diamonds and “real” natural diamonds.
The strategy has had mixed results. Lightbox succeeded in establishing price floors and in communicating that laboratory diamonds are manufactured goods with no scarcity, but it did not prevent the engagement ring market from migrating toward laboratory-grown at a rate that has reduced natural diamond demand in the sub-2-carat segment by an estimated 20 to 30 percent in major Western markets between 2020 and 2024. De Beers’ own rough diamond sales fell from approximately $6 billion annually in 2014 to $3.5 billion in 2023, driven partly by market share loss and partly by broader consumer spending shifts.
The Natural Diamond Council, a marketing consortium that includes De Beers, Alrosa (the Russian mining company, now operating under sanctions complications), Rio Tinto, and Dominion Diamond, has invested heavily in the “rare, real, responsible” messaging framework. The framework attempts to connect natural diamonds to sustainability credentials through Kimberley Process certification and mine-level environmental programs, while positioning laboratory production as energy-intensive manufacturing that lacks the romantic narrative of geological formation. The energy argument has some factual basis — a CVD reactor requires 250 to 750 kilowatt-hours per carat of polished output, depending on the facility, which is significant but comparable to aluminum smelting — but it is complicated by the industry’s transition toward renewable energy-powered reactors in Iceland and other markets with clean electricity.
Investment-Grade Natural Diamonds: Where the Safe Harbor Exists
The price data on investment-grade natural diamonds — defined here as round brilliants above 3 carats in D-F color and VS1 or better clarity, GIA certified with Excellent cut — shows a different pattern from the commodity segment. At Christie’s and Sotheby’s, stones in this tier have maintained or modestly improved in value between 2021 and 2024, though the extraordinary pandemic-era auction prices of 2021 to 2022 represented a peak from which a 10 to 15 percent correction has occurred.
The argument for natural diamonds above the commodity threshold rests on supply-side reality: the significant natural diamond deposits are finite and are not growing. The Argyle mine in Western Australia — historically the world’s primary source of pink diamonds — closed in 2020. The Diavik and Ekati mines in Canada are operating on declining ore grades. Botswana’s Jwaneng and Orapa mines, the world’s most productive by value, are decades into their production lives. No significant new diamond discoveries have entered production since 2013. This supply constraint provides a structural floor for natural investment-grade stones that laboratory production cannot affect, because no one acquires a 10-carat D-Flawless diamond for the same reasons they acquire a 0.8-carat engagement stone.
Fancy colored natural diamonds — Fancy Vivid Pinks, Blues, and Purples — have performed distinctly well in this environment. The closure of the Argyle mine eliminated the primary source of pink diamonds of any quality, creating a supply vacuum in a category where demand has been strengthening among Asian collectors for twenty years. The Williamson Pink Star, a 11.15-carat Fancy Vivid Pink from the Williamson mine in Tanzania, sold at Sotheby’s Hong Kong in October 2022 for $57.7 million — $5.17 million per carat, a record for any gemstone at the time. These are specialist assets with specialist buyers, but they represent the far end of a spectrum where natural diamond scarcity is genuinely irreplaceable by any laboratory process.
What Buyers Should Conclude: A Segmented Decision Framework
The laboratory-grown versus natural diamond decision has become a segmented question rather than a binary one, and buyers are best served by recognizing which segment their purchase falls into. For fashion and everyday jewelry in sizes below 2 carats, laboratory-grown diamonds offer equivalent visual quality at dramatically lower prices — a category where value is primarily aesthetic and where resale is not the primary motivation. The retailer’s margin on laboratory goods is higher than on natural in the current market, creating an incentive to recommend laboratory product; buyers should be aware of this dynamic.
For engagement rings where the social and emotional significance of the purchase is weighted, the natural versus laboratory question involves values that are not resolvable by price analysis. Natural diamonds carry a narrative of scarcity, geological time, and physical rarity that some buyers find meaningful and others find irrelevant. Laboratory diamonds offer environmental framing advantages that are real but contested. Neither is an objectively superior choice.
For investment and collection purposes above the 3-carat threshold, natural diamonds remain the only defensible choice. Laboratory-grown diamonds at investment scale have no secondary market of meaningful depth and will not develop one as long as production costs continue to decline. A 5-carat D-Flawless natural diamond can be sold at Christie’s or Sotheby’s with competitive international bidding. The equivalent laboratory stone has no equivalent exit market.
The market disruption of laboratory-grown diamonds has clarified rather than confused the value proposition of fine natural stones. By commoditizing the lower end of the market, it has made visible what the upper end’s real premium is based on: irreplaceability, geological provenance, and the confirmation that a market of informed buyers has agreed on a price. These are durable characteristics that no manufacturing process will eliminate.
[ QUICK POLL // 60 SECONDS ]